ReviewEpilepsy research2026
Stress and HPA axis dysfunction impact diverse epilepsy outcomes including psychiatric comorbidities and SUDEP.
Review in Epilepsy research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Epilepsy is a chronic neurological disorder characterized by recurrent, spontaneous seizures. In addition to seizures, patients experience additional adverse outcomes, including increased risk of psychiatric comorbidities and premature mortality. Stress is the most commonly reported trigger for seizures and particularly severe or chronic stress has been linked to the development of epilepsy itself. Stress has also been found to worsen psychiatric illness and is a risk factor for sudden death in individuals with and without epilepsy. The body's response to stress is coordinated by the hypothalamic-pituitary-adrenal (HPA) axis. Perturbations in stress hormone levels and their receptors are associated with psychiatric illness as well as sudden unexpected death in epilepsy (SUDEP), which is the leading cause of death in patients with refractory epilepsy. This review examines our present understanding of the relationship between stress, HPA axis dysfunction, and epilepsy sequela. We highlight stress and HPA axis dysfunction as salient risk factors for epilepsy patients that may directly contribute to their prognoses. A better understanding of how stress facilitates deleterious outcomes in epilepsy will inform interventions to improve the quality of life and increase longevity in people with epilepsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.